IgG4 disease: a revised diagnosis of sarcoidosis after 36 years of treatment

Yu, Jonathan; Hall, Tim; Kale, Salvita; Phillips, Aled; Madge, Simon
August 2013
British Journal of Hospital Medicine (17508460);Aug2013, Vol. 74 Issue 8, p470
Academic Journal
Case Study
The article presents a case study of a 63-year-old man with a slowly enlarging right supra-orbital mass present for 36 years, and was diagnosed with sarcoidosis at the age of 27 years. As mentioned, he received long-glucocorticoids that reduced the mass growth, but it continued to enlarge and slowly covered his visual field. The article also states an excision biopsy performed and after a year of surgery, IgG4-related disease was diagnosed, which was eventually treated.


Related Articles

  • The Impact of Histologic Variants on FSGS Outcomes. Meliambro, Kristin; Schwartzman, Monica; Cravedi, Paolo; Campbell, Kirk N. // ISRN Otolaryngology;2014, p1 

    Focal segmental glomerulosclerosis (FSGS) is the most common glomerular disease leading to end-stage renal disease. The clinical course is highly variable with disparate responses to therapeutic intervention and rates of progression. Histologic variant subtype has been commonly used as a...

  • Meeting Coverage. More than one-fourth of rheumatoid arthritis patients respond to methotrexate-first strategy.  // Formulary;Feb2012, Vol. 47 Issue 2, p81 

    The article reports on a presentation which physician James O'Dell gave at the 2012 annual scientific meeting of the American College of Rheumatology, which was held in Chicago, Illinois. In the presentation O'Dell indicated that using the drug methotrexate followed by the possible use of other...

  • Selective case study describing the use of Apligraf on necrobiosis lipoidica associated with diabetes. Penny, H. L.; Faretta, M.; Rifkah, M.; Weaver, A.; Swires, A.; Spinazzola, J. // Journal of Wound Care;Feb2014 Supplement 1a, Vol. 23, pS12 

    Necrobiosis lipoidica is a rare skin disease characterised by large, well-demarcated, symmetrical plaques with overlying telangiectasias and atrophic, fibrotic features. The disease is associated with diabetes mellitus (1 in 300 cases), but can also be linked to other diseases such as rheumatoid...

  • CHALLENGING CASES. Engstrom Jr., Robert E. // Ocular Surgery News;7/25/2014 Supplement, p10 

    The article presents several case studies of patients suffering from ophthalmic disorders treated with ocriplasmin injection. The topics include medical aspects of a 71-year-old female patient presented with vitreomacular adhesion, a 73-year-old female patient with vitreomacular traction, and an...

  • Idiopathic retroperitoneal fibrosis: clinicopathologic features and outcome analysis. Yachoui, Ralph; Sehgal, Rahul; Carmichael, Brett // Clinical Rheumatology;Feb2016, Vol. 35 Issue 2, p401 

    To describe clinical features and outcomes of 26 patients with idiopathic retroperitoneal fibrosis from a single center, we reviewed medical records of consecutive patients with idiopathic retroperitoneal fibrosis evaluated at our facility from January 1, 1998 to December 31, 2013 for clinical...

  • Treatment of ulcerated necrobiosis lipoidica with ovine forestomach matrix. Simcock, J. W.; Than, M.; Ward, B. R.; May, B. C. H. // Journal of Wound Care;Jul2013, Vol. 22 Issue 7, p383 

    The article presents a case study of a 61-year-old woman with two chronic pretibial ulcerations for almost 28 years already. It says that the wound is diagnosed as necrobiosis lipoidica in its biopsy, wherein she undergone medical and surgical treatments such as intralesional steroids, excision,...

  • Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials. Saketkoo, Lesley Ann; Mittoo, Shikha; Huscher, Dörte; Khanna, Dinesh; Dellaripa, Paul F.; Distler, Oliver; Flaherty, Kevin R.; Frankel, Sid; Oddis, Chester V.; Denton, Christopher P.; Fischer, Aryeh; Kowal-Bielecka, Otylia M.; LeSage, Daphne; Merkel, Peter A.; Phillips, Kristine; Pittrow, David; Swigris, Jeffrey; Antoniou, Katerina; Baughman, Robert P.; Castelino, Flavia V. // Thorax;May2014, Vol. 69 Issue 5, p428 

    Rationale Clinical trial design in interstitial lung diseases (ILDs) has been hampered by lack of consensus on appropriate outcome measures for reliably assessing treatment response. In the setting of connective tissue diseases (CTDs), some measures of ILD disease activity and severity may be...

  • Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease. Parkes, Julie; Roderick, Paul; Harris, Scott; Day, Christopher; Mutimer, David; Collier, Jane; Lombard, Martin; Alexander, Graeme; Ramage, John; Dusheiko, Geoffrey; Wheatley, Mark; Gough, Carol; Burt, Alastair; Rosenberg, William // Gut;Sep2010, Vol. 59 Issue 9, p1245 

    BACKGROUND: Clinicians use fibrosis in a liver biopsy to predict clinical outcomes of chronic liver disease. The performance of non-invasive tests has been evaluated against histological assessment of fibrosis but use of clinical outcomes as the reference standard would be ideal. The enhanced...

  • Retina/Vitreous. Steroid implant effective, tolerable at 12 months. Hasson, Matt // Ocular Surgery News;9/10/2010, Vol. 28 Issue 17, p27 

    The article discusses a study by Doctor Julia A. Haller and colleagues which found that injecting dexamethasone intravitreal implants in patients' eyes who suffered from macular edema improved their vision after 60 days. The commercial name of this steroid is Ozurdex, and was injected in various...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics